Know more before you book.

You searched peptides side effects and got a wellness blog with no denominator. The FDA’s own page still names the risks for 17 withdrawn compounds.

You asked whether peptides are steroids, heard ‘no’, and stopped asking. That answer is true and it is not the one that keeps you out of trouble.

Searching retatrutide dosage gets you trial numbers with no protocol attached. Here is what the trials actually did, verified at the primary sources.

The peptide videos have views. The FDA has a public list naming the compounds sold to patients and stating what it does not know about each one.

You are comparing serums and clinic injections for hair thinning. Only two drugs carry FDA approval, and neither one is a peptide.

You read the nausea line and started the injection anyway. The Wegovy label also prints 22% nerve pain at 7.2 mg and pancreatitis that kills.

You read the nausea line once and started anyway. The FDA label says 56% get gut symptoms, one in fifteen stop, and pancreatitis can kill.

Retatrutide is not approved anywhere. The trials show the GI rates and a dysesthesia signal; regulators keep testing vials that hold something else.

You typed the label’s milligrams into a peptide calculator and drew the answer. The FDA logged 990 dosing-error reports for compounded semaglutide.

A 77-year-old was refused a GLP-1 over her birthday, then her scale stopped moving for three months. The tirzepatide withdrawal trial shows the last year of treatment adds about a…